Spring 2026 funding cycle: Applications available until Monday, March 2nd, 2pm PT.
- Call opens: Wednesday, January 28, 2026
- Deadline: Monday, March 2, 2026 (2:00 pm PST)
- Funding results: Available before end of June 2026
Amount available: $50,000 in direct costs for 1 year
Apply through the UCSF Resource Allocation Program (RAP) portal
The CFAR Mentored Scientist Award (our primary award program) is a mentoring and training grant targeted toward early stage (either at a senior stage of clinical or postdoctoral training or junior faculty) investigators at UCSF or affiliated partner institutes in the conduct of an HIV research project. These awards are designed to acquire preliminary data and research skills to prepare investigators for a future grant effort. Applicants for this award must indicate a faculty research mentor(s) who will commit to guiding the applicant throughout the duration of the proposed project.
Designation of Mentor
All Mentored award applications from individuals at the Assistant Professor level or below require an HIV research mentor. Mentors can, but are not required to, have supervisory authority over the applicant. CFAR requires your research mentor’s support to advise and guide the research portion of your application before submitting it to RAP.
Of high interest to CFAR are investigations ranging from basic pathogenesis to clinical outcomes in the research areas of HIV/aging and inflammation, latency, cure, vaccines, co-infections, HIV in women, implementation science, and research related to HIV-infected and HIV-impacted Bay Area populations. Projects must be within NIH’s HIV/AIDS research high or medium priority areas. Projects in closely related areas (e.g. TB, HCV, drug use, etc.) must be clearly linked to HIV in order to be eligible for CFAR funding.
The award amount is $50,000 in direct costs for one year.
CFAR requests that applicants review the NIAID HIV Language Guide as they prepare their proposals so that they can follow best practices on language for communicating respectfully about HIV and related topics, including the use of person-first, non-stigmatizing language. Please contact us if you have any questions about this request.
For more detailed information about this RFA, please see the RAP Portal.
To see examples of previously funded projects, see the list below.
Mentored Science Awardees
135 Awards
-
Defining the cellular and viral factors underlying HIV latency at the single cell level
Defining the cellular and viral factors underlying HIV latency at the single cell level
Abstract
Latently infected CD4+ T cells, thought to be the main barrier to HIV cure, are indistinguishable from uninfected cells and are exceedingly rare, rendering the study of HIV latency in vivo particularly challenging. The development of more tractable systems such as in vitro primary cell models of latency has greatly advanced our understanding of the establishment, maintenance and reactivation of HIV latency, since these models permit higher infection frequencies and some employ reporter viruses to readily distinguish latent and productively infected populations.
-
Defining the cellular and viral factors underlying HIV latency at the single cell level
Defining the cellular and viral factors underlying HIV latency at the single cell level
Abstract
Latently infected CD4+ T cells, thought to be the main barrier to HIV cure, are indistinguishable from uninfected cells and are exceedingly rare, rendering the study of HIV latency in vivo particularly challenging. The development of more tractable systems such as in vitro primary cell models of latency has greatly advanced our understanding of the establishment, maintenance and reactivation of HIV latency, since these models permit higher infection frequencies and some employ reporter viruses to readily distinguish latent and productively infected populations.
-
Locating perceptions of HIV acquisition and transmission risks among people who inject drugs in West Virginia
Locating perceptions of HIV acquisition and transmission risks among people who inject drugs in West Virginia
Abstract
West Virginia has some of the highest risk areas in the country for HIV transmission. Opioid use, particularly through injection, has risen dramatically in the state which also has the nation’s highest drug overdose death rate.
-
Locating perceptions of HIV acquisition and transmission risks among people who inject drugs in West Virginia
Locating perceptions of HIV acquisition and transmission risks among people who inject drugs in West Virginia
Abstract
West Virginia has some of the highest risk areas in the country for HIV transmission. Opioid use, particularly through injection, has risen dramatically in the state which also has the nation’s highest drug overdose death rate.
-
Exploring the intersection of food insecurity and violence among women in the Women’s Interagency HIV Study (WIHS)
Exploring the intersection of food insecurity and violence among women in the Women’s Interagency HIV Study (WIHS)
Abstract
Food insecurity, which refers to having limited or uncertain availability of nutritionally adequate and safe food, and violence are prevalent among women in the United States, and disproportionately affect HIV-positive women. Both food insecurity and violence are associated with negative health behaviors and outcomes including HIV risk behaviors, chronic diseases, poor mental health, and reduced engagement in HIV care and treatment. Evidence suggests that food insecurity is associated with increased risk for intimate partner violence (IPV).
-
Exploring the intersection of food insecurity and violence among women in the Women’s Interagency HIV Study (WIHS)
Exploring the intersection of food insecurity and violence among women in the Women’s Interagency HIV Study (WIHS)
Abstract
Food insecurity, which refers to having limited or uncertain availability of nutritionally adequate and safe food, and violence are prevalent among women in the United States, and disproportionately affect HIV-positive women. Both food insecurity and violence are associated with negative health behaviors and outcomes including HIV risk behaviors, chronic diseases, poor mental health, and reduced engagement in HIV care and treatment. Evidence suggests that food insecurity is associated with increased risk for intimate partner violence (IPV).
-
Are extracellular vesicles involved in the pathogenesis of HIV-associated cardiovascular disease?
Are extracellular vesicles involved in the pathogenesis of HIV-associated cardiovascular disease?
Abstract
HIV-infected individuals on antiretroviral therapy have higher than expected rates of cardiovascular disease (CVD) than uninfected individuals, and HIV-induced chronic inflammation is believed to be directly and causally associated with the accelerated atherosclerosis development. Prior studies have revealed that chronic inflammatory states, such as atherosclerosis, show significantly increased levels of circulating endothelium-derived extracellular vesicles (EVs), which are preferentially taken up by monocytes and lead to monocyte activation.
-
Are extracellular vesicles involved in the pathogenesis of HIV-associated cardiovascular disease?
Are extracellular vesicles involved in the pathogenesis of HIV-associated cardiovascular disease?
Abstract
HIV-infected individuals on antiretroviral therapy have higher than expected rates of cardiovascular disease (CVD) than uninfected individuals, and HIV-induced chronic inflammation is believed to be directly and causally associated with the accelerated atherosclerosis development. Prior studies have revealed that chronic inflammatory states, such as atherosclerosis, show significantly increased levels of circulating endothelium-derived extracellular vesicles (EVs), which are preferentially taken up by monocytes and lead to monocyte activation.
-
The role of pulmonary myeloid cells in HIV-related COPD in individuals on anti-retroviral therapy
The role of pulmonary myeloid cells in HIV-related COPD in individuals on anti-retroviral therapy
Abstract
Dr. Joshua Vásquez, MD, Assistant Professor in the Division of Experimental Medicine and the Division of Pulmonary and Critical Care Medicine at UCSF who is establishing himself as a clinician-scientist in HIV immunology. This award will provide him with preliminary data and support to apply for future funding for projects aimed at: (1) characterizing the pulmonary reservoir of HIV and (2) to determining whether defects in alveolar macrophages are associated with HIV-related chronic obstructive pulmonary disease and persist, despite antiretroviral therapy.
-
The role of pulmonary myeloid cells in HIV-related COPD in individuals on anti-retroviral therapy
The role of pulmonary myeloid cells in HIV-related COPD in individuals on anti-retroviral therapy
Abstract
Dr. Joshua Vásquez, MD, Assistant Professor in the Division of Experimental Medicine and the Division of Pulmonary and Critical Care Medicine at UCSF who is establishing himself as a clinician-scientist in HIV immunology. This award will provide him with preliminary data and support to apply for future funding for projects aimed at: (1) characterizing the pulmonary reservoir of HIV and (2) to determining whether defects in alveolar macrophages are associated with HIV-related chronic obstructive pulmonary disease and persist, despite antiretroviral therapy.